How effective is Qilu Pharmaceutical’s Tofacitinib?

Tofacitinib (Tofacitinib) produced by Qilu Pharmaceutical is a domestically produced drug. Its drug ingredients and efficacy are basically the same as those of the original drug. It is mainly used to treat and alleviate the disease, and cannot achieve the effect of completely curing the disease. Tofacitinib belongs to the Janus kinase (JAK) inhibitor class, which regulates immune responses and reduces inflammation by blocking JAKs. It is approved for the treatment of patients who have not responded to other disease-modifying antirheumatic drugs (DMARDs). Patients with moderate to severe rheumatoid arthritis (RA), ankylosing spondylitis (PsA), ulcerative colitis (UC), juvenile idiopathic arthritis (pcJIA).